General Information of the Compound
Compound ID
CP0544262
Compound Name
4-[2-[1-(3-chlorophenyl)-5-methylpyrazol-3-yl]oxyethyl]morpholine
    Show/Hide
Structure
Formula
C16H20ClN3O2
Molecular Weight
321.808
Canonical SMILES
Cc1cc(OCCN2CCOCC2)nn1-c1cccc(Cl)c1
    Show/Hide
InChI
InChI=1S/C16H20ClN3O2/c1-13-11-16(22-10-7-19-5-8-21-9-6-19)18-20(13)15-4-2-3-14(17)12-15/h2-4,11-12H,5-10H2,1H3
    Show/Hide
InChIKey
NZWIQLRQJPTXJU-UHFFFAOYSA-N
Physicochemical Property
logP
2.54512
Rotatable Bonds
5
Heavy Atom Count
22
Polar Areas
39.52
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71460635
SID: 163489037
ChEMBL ID
CHEMBL2170059
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 180 nM
   TI
   LI
   LO
   TS